liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments.
Unilever R&D Vlaardingen.
Centre for Oral Biology, Novum.
Unilever R&D Vlaardingen.
Unilever R&D Vlaardingen.
Show others and affiliations
2006 (English)In: Vaccine, ISSN 0264-410X, E-ISSN 1873-2518, Vol. 24, no 41, 4130-4137 p.Article in journal (Refereed) Published
Abstract [en]

Apart from the use of oral rehydration solution, there are currently no treatment modalities for rotavirus induced diarrhoea, which is particularly relevant to developing countries. Fragments derived from llama heavy chain antibodies were previously shown to be highly stable, efficiently produced in yeast and exhibiting high epitope specific affinity. We now aim to demonstrate that these antibody fragments are capable of reducing morbidity of rotavirus induced diarrhoea. Here we show the isolation of rotavirus specific antibody fragments and their capability of reducing the morbidity of rotavirus induced diarrhoea in vivo in mice. They could provide a treatment modality for the moderation of human rotavirus infections having a significant impact on the course of an often fatal childhood disease.

Place, publisher, year, edition, pages
2006. Vol. 24, no 41, 4130-4137 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-35939DOI: 10.1016/j.vaccine.2006.02.045Local ID: 29101OAI: diva2:256787
Available from: 2009-10-10 Created: 2009-10-10 Last updated: 2010-05-17

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Svensson, Lennart
In the same journal
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 38 hits
ReferencesLink to record
Permanent link

Direct link